22.86
price up icon3.44%   0.76
pre-market  プレマーケット:  22.61   -0.25   -1.09%
loading
前日終値:
$22.10
開ける:
$22.12
24時間の取引高:
771.88K
Relative Volume:
0.87
時価総額:
$939.55M
収益:
$681.75M
当期純損益:
$70.47M
株価収益率:
15.77
EPS:
1.45
ネットキャッシュフロー:
$173.19M
1週間 パフォーマンス:
-2.56%
1か月 パフォーマンス:
+10.54%
6か月 パフォーマンス:
-14.48%
1年 パフォーマンス:
-2.85%
1日の値動き範囲:
Value
$21.87
$22.99
1週間の範囲:
Value
$20.62
$23.73
52週間の値動き範囲:
Value
$18.80
$27.98

Pacira Biosciences Inc Stock (PCRX) Company Profile

Name
名前
Pacira Biosciences Inc
Name
セクター
Healthcare (1106)
Name
電話
650-242-8052
Name
住所
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Name
職員
790
Name
Twitter
Name
次回の収益日
2024-11-06
Name
最新のSEC提出書
Name
PCRX's Discussions on Twitter

Compare PCRX vs TAK, ZTS, HLN, TEVA, UTHR

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
PCRX
Pacira Biosciences Inc
22.86 908.31M 681.75M 70.47M 173.19M 1.45
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
18.22 57.12B 29.85B 776.90M 4.35B 0.2408
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
125.96 53.16B 9.47B 2.67B 2.28B 6.0218
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.47 47.25B 14.54B 2.22B 2.58B 0.4879
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
32.91 37.59B 17.41B 1.43B 1.00B 1.2182
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
490.21 21.85B 3.13B 1.27B 1.12B 26.39

Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-12-09 開始されました Barclays Equal Weight
2025-11-17 開始されました H.C. Wainwright Buy
2025-07-25 アップグレード Truist Hold → Buy
2025-01-30 アップグレード Truist Sell → Hold
2024-08-13 ダウングレード Truist Buy → Sell
2024-08-12 ダウングレード JP Morgan Overweight → Underweight
2024-08-12 ダウングレード Piper Sandler Overweight → Neutral
2024-08-12 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2024-08-12 ダウングレード Raymond James Outperform → Mkt Perform
2024-07-03 ダウングレード Barclays Overweight → Equal Weight
2024-03-07 再開されました JP Morgan Overweight
2023-12-20 開始されました Raymond James Outperform
2023-08-03 アップグレード TD Cowen Market Perform → Outperform
2023-01-31 再開されました Wedbush Outperform
2022-10-21 再開されました Jefferies Buy
2022-01-03 再開されました JP Morgan Overweight
2021-07-26 アップグレード JP Morgan Neutral → Overweight
2021-04-21 再開されました JP Morgan Neutral
2021-04-09 開始されました Berenberg Buy
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-11 ダウングレード Northland Capital Outperform → Market Perform
2021-01-21 ダウングレード SVB Leerink Outperform → Mkt Perform
2020-09-21 アップグレード Northland Capital Market Perform → Outperform
2020-07-06 繰り返されました Needham Buy
2020-05-27 開始されました Guggenheim Neutral
2020-04-07 開始されました Northland Capital Outperform
2020-03-20 アップグレード SVB Leerink Mkt Perform → Outperform
2020-02-24 繰り返されました H.C. Wainwright Buy
2020-01-24 開始されました SunTrust Buy
2020-01-23 開始されました SunTrust Buy
2019-11-06 開始されました BTIG Research Buy
2019-06-11 開始されました Barclays Overweight
2019-05-06 アップグレード Mizuho Underperform → Neutral
2019-05-02 アップグレード Stifel Sell → Hold
2019-02-01 ダウングレード Mizuho Neutral → Underperform
2018-08-06 ダウングレード BofA/Merrill Buy → Neutral
2018-04-09 繰り返されました H.C. Wainwright Buy
2018-03-21 繰り返されました Mizuho Neutral
2018-02-16 ダウングレード Needham Buy → Hold
2018-01-19 開始されました Seaport Global Securities Buy
2018-01-04 繰り返されました Canaccord Genuity Buy
2018-01-03 開始されました Leerink Partners Mkt Perform
すべてを表示

Pacira Biosciences Inc (PCRX) 最新ニュース

pulisher
Mar 04, 2026

Vanguard Group Inc. Trims Holdings in Pacira BioSciences, Inc. $PCRX - MarketBeat

Mar 04, 2026
pulisher
Mar 04, 2026

Pacira BioSciences to Participate in Fireside Chat at the Barclays 28th Annual Global Healthcare Conference - The Manila Times

Mar 04, 2026
pulisher
Mar 04, 2026

Pacira BioSciences, Inc. (NASDAQ:PCRX) Q4 2025 Earnings Call Transcript - Insider Monkey

Mar 04, 2026
pulisher
Mar 03, 2026

Pacira BioSciences (NASDAQ:PCRX) Stock Price Up 4.6%What's Next? - MarketBeat

Mar 03, 2026
pulisher
Mar 02, 2026

PCRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026
pulisher
Mar 02, 2026

Pacira BioSciences Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry (IGOR) - Bitget

Mar 02, 2026
pulisher
Mar 02, 2026

Pacira BioSciences (PCRX) Shows Promising Results in Knee Surger - GuruFocus

Mar 02, 2026
pulisher
Mar 02, 2026

Pacira BioSciences, Inc. Presents Two Real-World Studies from Its Innovations in Genicular Outcomes Registry - marketscreener.com

Mar 02, 2026
pulisher
Mar 02, 2026

PCRX Earnings History & Surprises | EPS & Revenue Results | PACIRA BIOSCIENCES INC (NASDAQ:PCRX) - ChartMill

Mar 02, 2026
pulisher
Mar 01, 2026

Pacira BioSciences (PCRX) Valuation Check After Mixed Share Performance And High P/E Multiple - Sahm

Mar 01, 2026
pulisher
Feb 28, 2026

Assessing Pacira BioSciences (PCRX) Valuation After Recent Share Price Weakness - Yahoo Finance

Feb 28, 2026
pulisher
Feb 28, 2026

Pacira BioSciences Q4 Earnings and Revenues Miss Estimates, Stock Down - The Globe and Mail

Feb 28, 2026
pulisher
Feb 27, 2026

Pacira BioSciences, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:PCRX) 2026-02-27 - Seeking Alpha

Feb 27, 2026
pulisher
Feb 27, 2026

Pacira BioSciences (NASDAQ:PCRX) Shares Gap DownWhat's Next? - MarketBeat

Feb 27, 2026
pulisher
Feb 27, 2026

Truist Adjusts Price Target on Pacira Biosciences to $27 From $28, Maintains Buy Rating - marketscreener.com

Feb 27, 2026
pulisher
Feb 27, 2026

Pacira BioSciences, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 27, 2026
pulisher
Feb 27, 2026

Pacira BioSciences Q4 Profit Return Tests Bullish Turnaround Narrative - Sahm

Feb 27, 2026
pulisher
Feb 27, 2026

Pacira BioSciences Q4 Earnings Call Highlights - Yahoo Finance

Feb 27, 2026
pulisher
Feb 27, 2026

Pacira BioSciences Inc (PCRX) Q4 2025 Earnings Call Highlights: - GuruFocus

Feb 27, 2026
pulisher
Feb 26, 2026

Pacira BioSciences (NASDAQ:PCRX) Releases Earnings Results, Misses Expectations By $0.28 EPS - MarketBeat

Feb 26, 2026
pulisher
Feb 26, 2026

Pacira BioSciences reports fourth quarter and full-year 2025 financial results - marketscreener.com

Feb 26, 2026
pulisher
Feb 26, 2026

Pacira Biosciences slips as 2026 revenue guidance, Q4 2025 results disappoint - MSN

Feb 26, 2026
pulisher
Feb 26, 2026

Pacira Biosciences Reports Fourth Quarter And Full-Year 2025 Financial Results - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Pacira (PCRX) Q4 2025 Earnings Call Transcript - AOL.com

Feb 26, 2026
pulisher
Feb 26, 2026

Pacira Biosciences (PCRX) Projects Robust Growth in FY26 with St - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Pacira Biosciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Q4 2025 Pacira Biosciences Inc Earnings Call Transcript - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

Pacira BioSciences Inc. (PCRX) Stock Falls on Q4 2025 Earnings - Quiver Quantitative

Feb 26, 2026
pulisher
Feb 26, 2026

Pacira BioSciences Q4 Earnings Assessment - Benzinga

Feb 26, 2026
pulisher
Feb 26, 2026

BRIEF-Pacira Biosciences FY Adjusted EBITDA USD 186.5 Million Vs. IBES Estimate USD 204 Million - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results - GlobeNewswire

Feb 26, 2026
pulisher
Feb 24, 2026

Pacira BioSciences, Inc. (PCRX) Stock Analysis: A Healthcare Innovator with 28.58% Potential Upside - DirectorsTalk Interviews

Feb 24, 2026
pulisher
Feb 24, 2026

Pacira Biosciences, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo

Feb 24, 2026
pulisher
Feb 24, 2026

Pacira BioSciences, Inc. $PCRX Shares Acquired by Doma Perpetual Capital Management LLC - MarketBeat

Feb 24, 2026
pulisher
Feb 23, 2026

Pacira BioSciences, Inc. (NASDAQ:PCRX) Given Average Recommendation of "Hold" by Analysts - MarketBeat

Feb 23, 2026
pulisher
Feb 21, 2026

Can Pacira BioSciences Inc expand its profit margins2025 Valuation Update & Detailed Earnings Play Alerts - baoquankhu1.vn

Feb 21, 2026
pulisher
Feb 20, 2026

Pacira Biosciences (PCRX) Securities Lawsuit Dismissed by New Jersey Federal Court - TipRanks

Feb 20, 2026
pulisher
Feb 20, 2026

Can Pacira BioSciences Inc. stock deliver sustainable ROEQuarterly Profit Review & AI Driven Stock Reports - mfd.ru

Feb 20, 2026
pulisher
Feb 19, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire

Feb 19, 2026
pulisher
Feb 19, 2026

MSN Money - MSN

Feb 19, 2026
pulisher
Feb 19, 2026

Pacira BioSciences (PCRX) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 19, 2026
pulisher
Feb 18, 2026

Bronstein, Gewirtz & Grossman, LLC Is Investigating Pacira BioSciences, Inc. (PCRX) And Encourages Stockholders to Connect - ACCESS Newswire

Feb 18, 2026
pulisher
Feb 17, 2026

Pacira BioSciences, Inc. (PCRX) Stock Analysis: A Closer Look at Its 36.49% Potential Upside - DirectorsTalk Interviews

Feb 17, 2026
pulisher
Feb 16, 2026

Is Pacira BioSciences Inc. trading at a discountEarnings Risk Report & Consistent Profit Trade Alerts - mfd.ru

Feb 16, 2026
pulisher
Feb 15, 2026

Understanding Momentum Shifts in (PCRX) - Stock Traders Daily

Feb 15, 2026
pulisher
Feb 15, 2026

Will Pacira BioSciences Inc. (82P) stock gain from lower interest ratesWeekly Trade Summary & AI Based Buy/Sell Signal Reports - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Should you avoid Pacira BioSciences Inc. stock right nowLong Setup & AI Enhanced Trading Signals - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

PCRX Investors Have Opportunity to Lead Pacira BioSciences, Inc. Securities Fraud Lawsuit - GuruFocus

Feb 13, 2026
pulisher
Feb 13, 2026

Should you avoid Pacira BioSciences Inc stock right nowJuly 2025 Setups & Advanced Swing Trade Entry Alerts - baoquankhu1.vn

Feb 13, 2026
pulisher
Feb 13, 2026

Pacira BioSciences (PCRX) CEO receives 261,818 stock units award - Stock Titan

Feb 13, 2026
pulisher
Feb 12, 2026

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Pacira BioSciences, Inc. (PCRX) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire

Feb 12, 2026

Pacira Biosciences Inc (PCRX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_specialty_generic RDY
$14.28
price up icon 0.21%
$24.44
price down icon 1.77%
drug_manufacturers_specialty_generic RGC
$25.45
price up icon 6.09%
$133.44
price up icon 1.75%
$14.71
price down icon 1.21%
$490.21
price down icon 1.69%
大文字化:     |  ボリューム (24 時間):